Acadia Pharmaceuticals
ACAD
ACAD
232 hedge funds and large institutions have $2.97B invested in Acadia Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 76 increasing their positions, 70 reducing their positions, and 27 closing their positions.
Holders
232
Holders Change
+6
Holders Change %
+2.65%
% of All Funds
3.71%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
35
Increased
76
Reduced
70
Closed
27
Calls
$10.9M
Puts
$4.48M
Net Calls
+$6.39M
Net Calls Change
-$939K
Top Buyers
1 |
RI
1
RTW Investments
New York
|
$155M |
2 |
![]()
2
Adage Capital Partners
Boston,
Massachusetts
|
$23.1M |
3 |
3
Morgan Stanley
New York
|
$73.7M |
4 |
4
D.E. Shaw & Co
New York
|
$92.2M |
5 |
PAMS
5
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
$16.6M |